ByteBrief
We're a portrait publication through and through. Turn your phone back and your briefing picks up right where you left it.
(We tried widescreen once. It wasn't us.)

The FDA approved Gilead's new once-daily HIV pill for patients on complex regimens. The drug consolidates multiple medications into a single daily dose, simplifying treatment for those with challenging schedules. Gilead's approval marks a significant step in HIV care management.
Tap to vote and see what everyone thinks.
Summary by ByteBrief